Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7UY1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,542
Award facts
- Contract value 100% obligated
- $37,541.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,541.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on January 6, 2026, with completion scheduled for January 7, 2026. This non-set-aside award was issued as a child contract under AmerisourceBergen's parent company, Cencora, Inc. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic therapeutic commonly prescribed for moderate-to-severe atopic dermatitis, eosinophilic conditions, and asthma, making this procurement part of the Defense Health Agency's pharmaceutical supply requirements for military treatment facilities and healthcare systems.
This delivery order is issued under Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 31, 2031), which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, as a major pharmaceutical distributor, has demonstrated consistent capability in fulfilling federal medical procurement needs through competitive awards covering diverse therapeutic domains including specialty medications, vaccines, and medical devices across military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7UY1?
SPE2DR26F7UY1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F7UY1 worth?
The government has obligated $37,542 on SPE2DR26F7UY1.
Is contract SPE2DR26F7UY1 an order under another contract?
Yes. SPE2DR26F7UY1 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UY1 competed?
The extent of competition for SPE2DR26F7UY1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award